Sajid Jalil, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jalil’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C192636 · Current
Licensed to practise in California · since 2024 · expires 2028-03-31 · Aga Khan University, Aga Khan Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$63,902
Medicare paid this office $63,902 for 396 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 51 | $9,731 | $171 |
| Return visit (30+ min) | 67 | $8,837 | $118 |
| New patient visit (45+ min) | 40 | $5,937 | $148 |
| New patient visit (60+ min) | 28 | $5,290 | $189 |
| Measurement of liver stiffness | 144 | $4,311 | $30 |
See all 12 services
| Long return visit (40+ min) | 51 | $9,731 | $171 |
| Return visit (30+ min) | 67 | $8,837 | $118 |
| New patient visit (45+ min) | 40 | $5,937 | $148 |
| New patient visit (60+ min) | 28 | $5,290 | $189 |
| Measurement of liver stiffness | 144 | $4,311 | $30 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,526 | $230 |
| Long return visit (40+ min) | 17 | $2,223 | $123 |
| Biopsy of large bowel using a flexible endoscope | 14 | $1,753 | $125 |
| Return visit (30+ min) | 15 | $1,298 | $87 |
| Short return visit (20+ min) | 14 | $1,235 | $88 |
| New patient visit (30+ min) | 12 | $1,152 | $96 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 24 | $123 | $5 |
Procedures Medicare counted
| Colonoscopy | 43 | More than 60% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 31 | More than 56% of doctors who do this |
Who their Medicare patients are
396 Original Medicare patients in 2024. Average age 70 · Under 65 14% · 85 and older 4% · Women 55% · Also on Medicaid 33% · Health risk score 1.95. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 69% · Diabetes 42% · Chronic kidney disease 26% · Coronary heart disease 24% · Depression 19% · Atrial fibrillation 17% · Heart failure 16% · Cancer 16% · COPD 10% · Dementia 7% · Stroke 7%.
The office billed $395,877, Medicare allowed $80,520 and paid $63,902; for 601 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 396 | 601 | 70 | 1.95 | $395,877 | $63,902 |
| 2023 | 251 | 456 | 68 | 2.70 | $204,576 | $45,932 |
| 2022 | 255 | 622 | 66 | 2.68 | $259,604 | $58,757 |
| 2021 | 274 | 535 | 68 | 2.44 | $262,382 | $55,342 |
| 2020 | 251 | 421 | 68 | 2.79 | $232,101 | $47,716 |
| 2019 | 430 | 800 | 70 | 1.79 | $443,742 | $63,040 |
| 2018 | 551 | 1,110 | 69 | 1.27 | $690,925 | $87,992 |
| 2017 | 542 | 1,155 | 69 | 1.41 | $647,970 | $87,811 |
| 2016 | 550 | 811 | 69 | 1.45 | $604,960 | $92,851 |
| 2015 | 515 | 836 | 70 | 1.46 | $501,855 | $100,192 |
| 2014 | 536 | 945 | 70 | 1.19 | $517,320 | $100,521 |
| 2013 | 548 | 863 | 69 | 1.21 | $478,936 | $100,830 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $11,256 | $92 |
| Return visit (30+ min) | 48 | $4,421 | $75 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,706 | $100 |
| Long return visit (40+ min) | 17 | $1,971 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,826 | $130 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,366 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,208 | $60 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $978 | $82 |
| Short return visit (20+ min) | 17 | $893 | $53 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 12 | $265 | $18 |
2022: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $16,299 | $79 |
| Return visit (30+ min) | 47 | $4,003 | $67 |
| New patient visit (45+ min) | 25 | $2,550 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,466 | $154 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,393 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,245 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,203 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,458 | $56 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,231 | $72 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 15 | $1,014 | $63 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 25 | $503 | $19 |
2021: 14 services
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 14 | $6,102 | $321 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $5,597 | $82 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 22 | $4,272 | $186 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,124 | $109 |
| Return visit (30+ min) | 36 | $4,068 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $2,327 | $68 |
| New patient visit (45+ min) | 22 | $2,158 | $98 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,022 | $81 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,533 | $85 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,103 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,031 | $57 |
| Short return visit (20+ min) | 11 | $623 | $57 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 23 | $608 | $23 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 16 | $67 | $4 |
2020: 11 services
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 12 | $6,455 | $340 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,363 | $112 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 11 | $3,704 | $265 |
| New patient visit (45+ min) | 32 | $3,314 | $104 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,061 | $187 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $1,909 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,703 | $74 |
| Return visit (30+ min) | 21 | $1,685 | $67 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 26 | $975 | $29 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $731 | $52 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $69 | $5 |
2019: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $16,075 | $191 |
| Return visit (30+ min) | 84 | $4,854 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,564 | $109 |
| Biopsy of large bowel using a flexible endoscope | 40 | $4,313 | $108 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $3,738 | $66 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,083 | $181 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,036 | $74 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,573 | $121 |
| Return visit (30+ min) | 17 | $1,480 | $87 |
| New patient visit (45+ min) | 12 | $1,187 | $99 |
| Short return visit (20+ min) | 23 | $912 | $38 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 177 | $792 | $4 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 11 | $370 | $28 |
2018: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 126 | $25,076 | $197 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 47 | $8,519 | $174 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 43 | $7,812 | $182 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 97 | $7,586 | $75 |
| Return visit (30+ min) | 76 | $5,286 | $53 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $4,779 | $81 |
| Biopsy of large bowel using a flexible endoscope | 38 | $4,476 | $118 |
| Diagnostic exam of large bowel using a flexible endoscope | 27 | $3,758 | $139 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,596 | $113 |
| New patient visit (45+ min) | 20 | $1,709 | $85 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 334 | $1,523 | $4 |
| Short return visit (20+ min) | 19 | $641 | $34 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 12 | $89 | $7 |
2017: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 148 | $30,023 | $200 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $8,439 | $80 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $6,068 | $178 |
| Return visit (30+ min) | 88 | $6,000 | $52 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 32 | $5,642 | $176 |
| Diagnostic exam of large bowel using a flexible endoscope | 35 | $4,341 | $124 |
| New patient visit (45+ min) | 45 | $4,142 | $92 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $3,484 | $83 |
| Biopsy of large bowel using a flexible endoscope | 32 | $2,725 | $85 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 14 | $1,800 | $106 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 308 | $1,376 | $4 |
| Short return visit (20+ min) | 29 | $1,077 | $31 |
| Measurement of liver stiffness | 13 | $108 | $8 |
| Insertion of needle into vein for collection of blood sample | 13 | $59 | $3 |
2016: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 182 | $36,804 | $202 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 48 | $8,849 | $184 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | $7,335 | $188 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $5,087 | $72 |
| Return visit (30+ min) | 70 | $4,924 | $54 |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | $4,275 | $138 |
| Biopsy of large bowel using a flexible endoscope | 32 | $3,431 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,187 | $94 |
| Short return visit (20+ min) | 59 | $2,584 | $31 |
| New patient visit (45+ min) | 28 | $2,557 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,163 | $106 |
2015: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | $31,756 | $248 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 75 | $7,917 | $101 |
| Diagnostic exam of large bowel using a flexible endoscope | 40 | $6,754 | $165 |
| Biopsy of large bowel using a flexible endoscope | 44 | $6,729 | $153 |
| Short return visit (20+ min) | 85 | $4,078 | $37 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | $4,028 | $212 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,988 | $210 |
| Return visit (30+ min) | 50 | $3,936 | $60 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $3,679 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,946 | $59 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $1,889 | $82 |
| New patient visit (45+ min) | 17 | $1,789 | $105 |
| New patient visit (30+ min) | 31 | $1,644 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,560 | $111 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $380 | $32 |
2014: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 152 | $35,709 | $235 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $7,201 | $200 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $7,071 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 31 | $6,075 | $190 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,711 | $94 |
| Biopsy of large bowel using a flexible endoscope | 32 | $4,517 | $141 |
| Return visit (30+ min) | 58 | $4,515 | $54 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,147 | $150 |
| Short return visit (20+ min) | 69 | $2,931 | $33 |
| New patient visit (45+ min) | 29 | $2,814 | $97 |
| New patient visit (30+ min) | 18 | $985 | $55 |
| Study of esophagus to assess movement | 11 | $586 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $363 | $30 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 15 | $275 | $10 |
| Insertion of needle into vein for collection of blood sample | 30 | $129 | $3 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 15 | $124 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 11 | $104 | $9 |
2013: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 150 | $35,143 | $233 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $8,831 | $201 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $6,540 | $93 |
| Diagnostic exam of large bowel using a flexible endoscope | 43 | $6,468 | $150 |
| Return visit (30+ min) | 70 | $4,980 | $52 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,932 | $97 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,780 | $199 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 11 | $3,446 | $215 |
| Biopsy of large bowel using a flexible endoscope | 24 | $2,800 | $117 |
| Short return visit (20+ min) | 61 | $2,484 | $33 |
| New patient visit (45+ min) | 25 | $2,398 | $96 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $1,571 | $131 |
| New patient visit (30+ min) | 29 | $1,553 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $982 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $810 | $54 |
| Study of esophagus to assess movement | 12 | $587 | $49 |
| Insertion of needle into vein for collection of blood sample | 25 | $95 | $3 |
Medicaid work
$608 in 2024
Medicaid paid $608 for 38 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 38 | $608 |
| 2024 | 38 | 1 | 14 | $608 |
| 2023 | 247 | 2 | 29 | $8,956 |
| 2022 | 1,221 | 14 | 46 | $33,819 |
| 2021 | 332 | 8 | 26 | $10,597 |
| 2020 | 84 | 3 | 14 | $1,919 |
| 2019 | 198 | 5 | 15 | $4,175 |
| 2018 | 58 | 2 | 22 | $7 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 192 | $6,280 |
| Return visit (30+ min) | 55 | $2,677 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 596 | $21,684 |
| Return visit (30+ min) | 99 | $4,995 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 19 | $1,356 |
| HEPATIC FUNCTION PANEL | 73 | $1,266 |
| ELECTROLYTE PANEL | 45 | $1,056 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $976 |
| Creatinine; blood | 47 | $512 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 34 | $436 |
| PROTHROMBIN TIME | 42 | $402 |
| ALPHA-FETOPROTEIN SERUM | 13 | $366 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 61 | $314 |
| Urea nitrogen; quantitative | 45 | $234 |
2021
| Return visit (30+ min) | 110 | $5,799 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 124 | $4,228 |
| HEPATIC FUNCTION PANEL | 14 | $425 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 14 | $78 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $68 |
| TISSUE EXAM BY PATHOLOGIST | 29 | $0 |
| Injection, midazolam hydrochloride, per 1 mg | 14 | $0 |
| Fentanyl citrate injection | 15 | $0 |
2020
| New patient visit (45+ min) | 27 | $1,419 |
| Return visit (30+ min) | 14 | $500 |
| Injection, propofol, 10 mg | 43 | $0 |
2019
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 28 | $2,169 |
| Return visit (30+ min) | 28 | $1,642 |
| TISSUE EXAM BY PATHOLOGIST | 39 | $334 |
| Fentanyl citrate injection | 50 | $15 |
| Injection, midazolam hydrochloride, per 1 mg | 53 | $15 |
2018
| Injection, midazolam hydrochloride, per 1 mg | 24 | $5 |
| Fentanyl citrate injection | 34 | $2 |
Drugs they prescribed that Part D paid
$138,021
Pharmacies billed $138,021 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
528 generic and 83 brand-name prescriptions · $138,021 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 22 | $34,885 | $1,586 |
| Ursodiol | 73 | $13,823 | $189 |
| Tacrolimus | 40 | $2,985 | $75 |
| Entecavir | 15 | $2,549 | $170 |
| Mycophenolate Mofetil | 21 | $2,070 | $99 |
See all 17 drugs
| Vemlidy | 22 | $34,885 | $1,586 |
| Ursodiol | 73 | $13,823 | $189 |
| Tacrolimus | 40 | $2,985 | $75 |
| Entecavir | 15 | $2,549 | $170 |
| Mycophenolate Mofetil | 21 | $2,070 | $99 |
| Lactulose | 27 | $714 | $26 |
| Tenofovir Disoproxil | 21 | $601 | $29 |
| Gavilyte-G | 40 | $576 | $14 |
| Azathioprine | 21 | $425 | $20 |
| Spironolactone | 33 | $381 | $12 |
| Peg 3350-Electrolyte | 16 | $342 | $21 |
| Peg-3350 and Electrolytes | 17 | $244 | $14 |
| Carvedilol | 51 | $186 | $4 |
| Pantoprazole | 20 | $155 | $8 |
| Furosemide | 25 | $102 | $4 |
| Prednisone | 11 | $30 | $3 |
| Atorvastatin | 11 | $9 | $1 |
Year by year
| 2024 | 611 | 191 | None | 14% | $138,021 |
| 2023 | 360 | 95 | None | 14% | $130,284 |
| 2022 | 366 | 108 | None | 11% | $215,682 |
| 2021 | 319 | 88 | 0% (0) | 18% | $452,421 |
| 2020 | 308 | 109 | None | 22% | $351,111 |
| 2019 | 857 | 284 | None | 28% | $301,711 |
| 2018 | 1,197 | 507 | None | 31% | $447,343 |
| 2017 | 1,144 | 474 | 1% (11) | 34% | $644,050 |
| 2016 | 1,227 | 475 | 1% (14) | 36% | $787,851 |
| 2015 | 1,129 | 397 | 2% (18) | 43% | $1,291,803 |
| 2014 | 1,319 | 361 | None | 37% | $1,680,760 |
| 2013 | 978 | 197 | None | None | $409,599 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Xifaxan | 21 | $71,514 | $3,405 |
| Ursodiol | 49 | $10,265 | $209 |
| Tacrolimus | 16 | $3,901 | $244 |
| Tenofovir Disoproxil | 11 | $867 | $79 |
| Spironolactone | 39 | $859 | $22 |
| Azathioprine | 23 | $771 | $34 |
| Omeprazole | 21 | $714 | $34 |
| Pantoprazole | 21 | $493 | $23 |
| Nadolol | 13 | $335 | $26 |
| Furosemide | 37 | $192 | $5 |
| Prednisone | 14 | $158 | $11 |
| Carvedilol | 11 | $41 | $4 |
2022: 11 drugs
| Ursodiol | 36 | $11,380 | $316 |
| Tenofovir Disoproxil | 16 | $4,518 | $282 |
| Spironolactone | 53 | $1,404 | $26 |
| Nadolol | 21 | $1,191 | $57 |
| Azathioprine | 27 | $1,051 | $39 |
| Omeprazole | 23 | $538 | $23 |
| Lactulose | 17 | $304 | $18 |
| Pantoprazole | 14 | $197 | $14 |
| Furosemide | 28 | $174 | $6 |
| Prednisone | 14 | $164 | $12 |
| Ciprofloxacin | 17 | $117 | $7 |
2021: 9 drugs
| Epclusa | 13 | $334,648 | $25,742 |
| Ursodiol | 35 | $8,501 | $243 |
| Spironolactone | 43 | $1,172 | $27 |
| Tenofovir Disoproxil | 13 | $545 | $42 |
| Azathioprine | 19 | $487 | $26 |
| Omeprazole | 25 | $374 | $15 |
| Prednisone | 25 | $247 | $10 |
| Propranolol | 12 | $157 | $13 |
| Furosemide | 17 | $120 | $7 |
2020: 11 drugs
| Xifaxan | 32 | $61,978 | $1,937 |
| Entecavir | 31 | $17,173 | $554 |
| Ursodiol | 27 | $9,699 | $359 |
| Tenofovir Disoproxil | 13 | $3,845 | $296 |
| Mycophenolate Mofetil | 12 | $614 | $51 |
| Lactulose | 26 | $399 | $15 |
| Omeprazole | 17 | $368 | $22 |
| Spironolactone | 15 | $300 | $20 |
| Gavilyte-G | 11 | $121 | $11 |
| Furosemide | 12 | $58 | $5 |
| Ciprofloxacin | 11 | $34 | $3 |
2019: 16 drugs
| Xifaxan | 69 | $169,932 | $2,463 |
| Ursodiol | 86 | $33,404 | $388 |
| Entecavir | 46 | $13,567 | $295 |
| Viread | 11 | $13,275 | $1,207 |
| Tenofovir Disoproxil | 37 | $6,546 | $177 |
| Lactulose | 57 | $2,257 | $40 |
| Azathioprine | 53 | $1,955 | $37 |
| Spironolactone | 63 | $1,432 | $23 |
| Nadolol | 16 | $1,339 | $84 |
| Gavilyte-G | 56 | $873 | $16 |
| Golytely | 51 | $775 | $15 |
| Omeprazole | 37 | $701 | $19 |
| Furosemide | 66 | $350 | $5 |
| Peg 3350-Electrolyte | 26 | $302 | $12 |
| Prednisone | 26 | $292 | $11 |
| Pantoprazole | 19 | $199 | $10 |
2018: 21 drugs
| Xifaxan | 49 | $113,349 | $2,313 |
| Humira | 13 | $63,850 | $4,912 |
| Ursodiol | 109 | $34,070 | $313 |
| Viread | 23 | $25,010 | $1,087 |
| Tenofovir Disoproxil | 30 | $9,422 | $314 |
| Azathioprine | 90 | $3,239 | $36 |
| Gavilyte-G | 174 | $2,885 | $17 |
| Entecavir | 12 | $2,817 | $235 |
| Mercaptopurine | 20 | $2,166 | $108 |
| Spironolactone | 89 | $2,130 | $24 |
| Golytely | 110 | $1,712 | $16 |
| Nadolol | 12 | $1,325 | $110 |
| Lactulose | 43 | $1,082 | $25 |
| Peg 3350-Electrolyte | 73 | $806 | $11 |
| Methotrexate | 11 | $763 | $69 |
| Omeprazole | 46 | $555 | $12 |
| Prednisone | 51 | $457 | $9 |
| Propranolol | 11 | $429 | $39 |
| Gavilyte-C | 21 | $315 | $15 |
| Furosemide | 59 | $296 | $5 |
| Pantoprazole | 26 | $229 | $9 |
2017: 22 drugs
| Xifaxan | 30 | $63,559 | $2,119 |
| Humira | 13 | $58,208 | $4,478 |
| Ursodiol | 121 | $40,309 | $333 |
| Viread | 29 | $30,522 | $1,052 |
| Entecavir | 11 | $4,227 | $384 |
| Mercaptopurine | 21 | $3,289 | $157 |
| Azathioprine | 61 | $2,639 | $43 |
| Gavilyte-G | 140 | $2,540 | $18 |
| Golytely | 124 | $1,849 | $15 |
| Moviprep | 15 | $1,498 | $100 |
| Spironolactone | 72 | $1,246 | $17 |
| Nadolol | 11 | $1,218 | $111 |
| Omeprazole | 85 | $905 | $11 |
| Lactulose | 41 | $895 | $22 |
| Peg 3350-Electrolyte | 42 | $523 | $12 |
| Prednisone | 41 | $489 | $12 |
| Propranolol | 17 | $406 | $24 |
| Gavilyte-C | 19 | $339 | $18 |
| Constulose | 16 | $268 | $17 |
| Furosemide | 63 | $266 | $4 |
| Peg-3350 and Electrolytes | 14 | $227 | $16 |
| Amlodipine Besylate | 11 | $34 | $3 |
2016: 22 drugs
| Xifaxan | 37 | $67,995 | $1,838 |
| Ursodiol | 163 | $55,598 | $341 |
| Humira | 13 | $51,545 | $3,965 |
| Viread | 25 | $24,997 | $1,000 |
| Mercaptopurine | 19 | $2,134 | $112 |
| Azathioprine | 40 | $2,127 | $53 |
| Gavilyte-G | 129 | $2,039 | $16 |
| Golytely | 110 | $1,636 | $15 |
| Nadolol | 15 | $1,584 | $106 |
| Moviprep | 15 | $1,427 | $95 |
| Spironolactone | 88 | $1,410 | $16 |
| Omeprazole | 101 | $794 | $8 |
| Peg 3350-Electrolyte | 56 | $606 | $11 |
| Peg-3350 and Electrolytes | 39 | $590 | $15 |
| Neomycin Sulfate | 12 | $495 | $41 |
| Lactulose | 29 | $473 | $16 |
| Prednisone | 41 | $458 | $11 |
| Constulose | 22 | $282 | $13 |
| Gavilyte-C | 14 | $233 | $17 |
| Furosemide | 58 | $166 | $3 |
| Atorvastatin | 12 | $75 | $6 |
| Tramadol | 12 | $25 | $2 |
2015: 26 drugs
| Harvoni | 26 | $825,297 | $31,742 |
| Xifaxan | 69 | $117,755 | $1,707 |
| Ursodiol | 113 | $47,926 | $424 |
| Humira | 13 | $42,318 | $3,255 |
| Viread | 15 | $14,475 | $965 |
| Budesonide Ec | 15 | $12,021 | $801 |
| Entecavir | 14 | $6,246 | $446 |
| Azathioprine | 47 | $3,153 | $67 |
| Mercaptopurine | 22 | $2,876 | $131 |
| Golytely | 150 | $2,270 | $15 |
| Spironolactone | 52 | $1,777 | $34 |
| Nadolol | 17 | $1,136 | $67 |
| Gavilyte-G | 60 | $947 | $16 |
| Lactulose | 53 | $894 | $17 |
| Omeprazole | 66 | $664 | $10 |
| Peg 3350-Electrolyte | 49 | $598 | $12 |
| Generlac | 11 | $359 | $33 |
| Peg-3350 and Electrolytes | 19 | $325 | $17 |
| Prednisone | 24 | $316 | $13 |
| Labetalol | 11 | $292 | $27 |
| Furosemide | 50 | $221 | $4 |
| Ciprofloxacin | 14 | $80 | $6 |
| Atorvastatin | 12 | $60 | $5 |
| Tramadol | 18 | $50 | $3 |
| Famotidine | 11 | $46 | $4 |
| Hydrochlorothiazide | 11 | $44 | $4 |
2014: 27 drugs
| Sovaldi | 28 | $788,393 | $28,157 |
| Olysio | 19 | $420,534 | $22,133 |
| Xifaxan | 47 | $62,339 | $1,326 |
| Humira | 19 | $51,082 | $2,689 |
| Ursodiol | 120 | $34,859 | $290 |
| Budesonide Ec | 14 | $11,775 | $841 |
| Nexium | 19 | $8,261 | $435 |
| Pentasa | 11 | $4,977 | $452 |
| Nadolol | 37 | $3,256 | $88 |
| Spironolactone | 111 | $3,253 | $29 |
| Mercaptopurine | 39 | $2,994 | $77 |
| Ribavirin | 17 | $2,497 | $147 |
| Azathioprine | 48 | $1,913 | $40 |
| Lactulose | 94 | $1,791 | $19 |
| Golytely | 111 | $1,777 | $16 |
| Omeprazole | 61 | $1,158 | $19 |
| Gavilyte-G | 49 | $832 | $17 |
| Peg 3350-Electrolyte | 63 | $801 | $13 |
| Furosemide | 141 | $567 | $4 |
| Labetalol | 13 | $411 | $32 |
| Prednisone | 33 | $355 | $11 |
| Peg-3350 and Electrolytes | 21 | $349 | $17 |
| Ciprofloxacin | 17 | $83 | $5 |
| Propranolol | 19 | $75 | $4 |
| Atorvastatin | 12 | $66 | $6 |
| Famotidine | 11 | $58 | $5 |
| Hydrochlorothiazide | 13 | $35 | $3 |
2013: 22 drugs
| Pegasys | 23 | $65,709 | $2,857 |
| Xifaxan | 35 | $46,242 | $1,321 |
| Humira | 11 | $30,255 | $2,750 |
| Ursodiol | 125 | $19,280 | $154 |
| Budesonide Ec | 15 | $16,471 | $1,098 |
| Lialda | 21 | $12,176 | $580 |
| Nexium | 14 | $6,108 | $436 |
| Ribavirin | 20 | $3,358 | $168 |
| Mercaptopurine | 38 | $2,680 | $71 |
| Spironolactone | 80 | $2,154 | $27 |
| Nadolol | 41 | $1,986 | $48 |
| Azathioprine | 57 | $1,471 | $26 |
| Omeprazole | 84 | $1,359 | $16 |
| Lactulose | 40 | $764 | $19 |
| Cholestyramine | 15 | $725 | $48 |
| Golytely | 33 | $511 | $15 |
| Furosemide | 78 | $316 | $4 |
| Prednisone | 35 | $301 | $9 |
| Gavilyte-G | 11 | $214 | $19 |
| Peg 3350-Electrolyte | 15 | $185 | $12 |
| Propranolol | 12 | $102 | $9 |
| Atorvastatin | 12 | $101 | $8 |
Money from drug and device companies
$626 in 2025
| 2025 | 6 | 7 | None | $626 |
| 2024 | 2 | 3 | None | $281 |
| 2023 | 1 | 1 | None | $128 |
| 2019 | 1 | 5 | None | $109 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Terlivaz | $261 | 2 payments
|
| Galvanize Therapeutics | Aliya System | $146 | 1 payment
|
| Ipsen Biopharmaceuticals | Iqirvo | $115 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $46 | 1 payment
|
| Mauna Kea Technologies | None | $29 | 1 payment
|
| Cook Medical | Echotip Insight | $28 | 1 payment
|
See all 7 published payments
| Ipsen Biopharmaceuticals | Meals · 2025-11-09 | Iqirvo | $115 |
| Mallinckrodt Hospital Products | Meals · 2025-08-03 | Terlivaz | $111 |
| Mauna Kea Technologies | Meals · 2025-07-21 | None | $29 |
| Cook Medical | Meals · 2025-05-05 | Echotip Insight | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-05-05 | Terlivaz | $150 |
| Madrigal Pharmaceuticals | Meals · 2025-05-03 | Rezdiffra | $46 |
| Galvanize Therapeutics | Meals · 2025-04-08 | Aliya System | $146 |
See earlier years (2024, 2023, 2019)
2024: $281
| Boston Scientific | Resolution 360 Ultra Clip | $146 | 2 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $136 | 1 payment
|
2023: $128
| Intercept Pharmaceuticals | Ocaliva | $128 | 1 payment
|
2019: $109
| Gilead Sciences | None | $109 | 5 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699989939
- Licence
- CA C192636California C192636: Current · expires 2028-03-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- OH 0376200
- Taxonomy
- Federal specialty code 207RI0008X (207RI0008X); Internal medicine (207R00000X); Federal specialty code 207RG0100X (207RG0100X); Federal specialty code 207RT0003X (207RT0003X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-05-09
- NPI last updated
- 2026-09-03
- NPI record certified
- 2026-09-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 410 W 10th Ave, Columbus, OH, 43210
This office lists an electronic records connection.